Clinical Trial Update: Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of GLPG1205 in active ulcerative colitis has completed, providing efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• GLPG1205

Snippet

Sponsor: Galapagos NV | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED